Pharmacologic management of pain in patients with Chikungunya: a guideline

Abstract From the arrival of Chikungunya virus in the Americas in 2013 until March 2016, approximately two million cases of the disease have been reported. In Brazil, the virus was identified in 2014 and thousands of people have been affected. The disease has high attack rates, infecting 50% of a po...

Full description

Bibliographic Details
Main Authors: Carlos Alexandre Antunes de Brito, Ana Karla Arraes von Sohsten, Clezio Cordeiro de Sá Leitão, Rita de Cássia Coelho Moraes de Brito, Lilian David De Azevedo Valadares, Caroline Araújo Magnata da Fonte, Zelina Barbosa de Mesquita, Rivaldo Venâncio Cunha, Kleber Luz, Helena Maria Carneiro Leão, Cecília Moraes de Brito, Lívia Carla Vinhal Frutuoso
Format: Article
Language:English
Published: Sociedade Brasileira de Medicina Tropical (SBMT)
Series:Revista da Sociedade Brasileira de Medicina Tropical
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822016000600668&lng=en&tlng=en
id doaj-e6508ba01f2b47f0bb582980694e9503
record_format Article
spelling doaj-e6508ba01f2b47f0bb582980694e95032020-11-24T22:46:46ZengSociedade Brasileira de Medicina Tropical (SBMT)Revista da Sociedade Brasileira de Medicina Tropical1678-984949666867910.1590/0037-8682-0279-2016S0037-86822016000600668Pharmacologic management of pain in patients with Chikungunya: a guidelineCarlos Alexandre Antunes de BritoAna Karla Arraes von SohstenClezio Cordeiro de Sá LeitãoRita de Cássia Coelho Moraes de BritoLilian David De Azevedo ValadaresCaroline Araújo Magnata da FonteZelina Barbosa de MesquitaRivaldo Venâncio CunhaKleber LuzHelena Maria Carneiro LeãoCecília Moraes de BritoLívia Carla Vinhal FrutuosoAbstract From the arrival of Chikungunya virus in the Americas in 2013 until March 2016, approximately two million cases of the disease have been reported. In Brazil, the virus was identified in 2014 and thousands of people have been affected. The disease has high attack rates, infecting 50% of a population within a few months. Approximately 50% of infected people develop chronic symptoms lasting for months or years. Joint involvement is the main clinical manifestation of Chikungunya. It is characterized by swelling and intense pain that is poorly responsive to analgesics, both in the acute and chronic phase of the disease. This significantly compromises quality of life and may have immeasurable psychosocial and economic repercussions, constituting therefore, a serious public health problem requiring a targeted approach. Physicians are often not familiar with how to approach the management of pain, frequently prescribing limited analgesics, such as dipyrone, in sub-therapeutic doses. In addition, there are few published studies or guidelines on the approach to the treatment of pain in patients with Chikungunya. Some groups of specialists from different fields have thus developed a protocol for the pharmacologic treatment of Chikungunya-associated acute and chronic joint pain; this will be presented in this review.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822016000600668&lng=en&tlng=enChikungunyaPainArthralgiaArbovirusTreatment
collection DOAJ
language English
format Article
sources DOAJ
author Carlos Alexandre Antunes de Brito
Ana Karla Arraes von Sohsten
Clezio Cordeiro de Sá Leitão
Rita de Cássia Coelho Moraes de Brito
Lilian David De Azevedo Valadares
Caroline Araújo Magnata da Fonte
Zelina Barbosa de Mesquita
Rivaldo Venâncio Cunha
Kleber Luz
Helena Maria Carneiro Leão
Cecília Moraes de Brito
Lívia Carla Vinhal Frutuoso
spellingShingle Carlos Alexandre Antunes de Brito
Ana Karla Arraes von Sohsten
Clezio Cordeiro de Sá Leitão
Rita de Cássia Coelho Moraes de Brito
Lilian David De Azevedo Valadares
Caroline Araújo Magnata da Fonte
Zelina Barbosa de Mesquita
Rivaldo Venâncio Cunha
Kleber Luz
Helena Maria Carneiro Leão
Cecília Moraes de Brito
Lívia Carla Vinhal Frutuoso
Pharmacologic management of pain in patients with Chikungunya: a guideline
Revista da Sociedade Brasileira de Medicina Tropical
Chikungunya
Pain
Arthralgia
Arbovirus
Treatment
author_facet Carlos Alexandre Antunes de Brito
Ana Karla Arraes von Sohsten
Clezio Cordeiro de Sá Leitão
Rita de Cássia Coelho Moraes de Brito
Lilian David De Azevedo Valadares
Caroline Araújo Magnata da Fonte
Zelina Barbosa de Mesquita
Rivaldo Venâncio Cunha
Kleber Luz
Helena Maria Carneiro Leão
Cecília Moraes de Brito
Lívia Carla Vinhal Frutuoso
author_sort Carlos Alexandre Antunes de Brito
title Pharmacologic management of pain in patients with Chikungunya: a guideline
title_short Pharmacologic management of pain in patients with Chikungunya: a guideline
title_full Pharmacologic management of pain in patients with Chikungunya: a guideline
title_fullStr Pharmacologic management of pain in patients with Chikungunya: a guideline
title_full_unstemmed Pharmacologic management of pain in patients with Chikungunya: a guideline
title_sort pharmacologic management of pain in patients with chikungunya: a guideline
publisher Sociedade Brasileira de Medicina Tropical (SBMT)
series Revista da Sociedade Brasileira de Medicina Tropical
issn 1678-9849
description Abstract From the arrival of Chikungunya virus in the Americas in 2013 until March 2016, approximately two million cases of the disease have been reported. In Brazil, the virus was identified in 2014 and thousands of people have been affected. The disease has high attack rates, infecting 50% of a population within a few months. Approximately 50% of infected people develop chronic symptoms lasting for months or years. Joint involvement is the main clinical manifestation of Chikungunya. It is characterized by swelling and intense pain that is poorly responsive to analgesics, both in the acute and chronic phase of the disease. This significantly compromises quality of life and may have immeasurable psychosocial and economic repercussions, constituting therefore, a serious public health problem requiring a targeted approach. Physicians are often not familiar with how to approach the management of pain, frequently prescribing limited analgesics, such as dipyrone, in sub-therapeutic doses. In addition, there are few published studies or guidelines on the approach to the treatment of pain in patients with Chikungunya. Some groups of specialists from different fields have thus developed a protocol for the pharmacologic treatment of Chikungunya-associated acute and chronic joint pain; this will be presented in this review.
topic Chikungunya
Pain
Arthralgia
Arbovirus
Treatment
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822016000600668&lng=en&tlng=en
work_keys_str_mv AT carlosalexandreantunesdebrito pharmacologicmanagementofpaininpatientswithchikungunyaaguideline
AT anakarlaarraesvonsohsten pharmacologicmanagementofpaininpatientswithchikungunyaaguideline
AT cleziocordeirodesaleitao pharmacologicmanagementofpaininpatientswithchikungunyaaguideline
AT ritadecassiacoelhomoraesdebrito pharmacologicmanagementofpaininpatientswithchikungunyaaguideline
AT liliandaviddeazevedovaladares pharmacologicmanagementofpaininpatientswithchikungunyaaguideline
AT carolinearaujomagnatadafonte pharmacologicmanagementofpaininpatientswithchikungunyaaguideline
AT zelinabarbosademesquita pharmacologicmanagementofpaininpatientswithchikungunyaaguideline
AT rivaldovenanciocunha pharmacologicmanagementofpaininpatientswithchikungunyaaguideline
AT kleberluz pharmacologicmanagementofpaininpatientswithchikungunyaaguideline
AT helenamariacarneiroleao pharmacologicmanagementofpaininpatientswithchikungunyaaguideline
AT ceciliamoraesdebrito pharmacologicmanagementofpaininpatientswithchikungunyaaguideline
AT liviacarlavinhalfrutuoso pharmacologicmanagementofpaininpatientswithchikungunyaaguideline
_version_ 1725683883041619968